Indications, Efficacy and Safety of Anti-RS Virus Monoclonal Antibody Palivizumab (Synagis) for Pediatric Patients With Congenital Heart Diseases.
- Author:
Ben Tsutomu SAJI
1
Author Information
1. Division of Pediatric Cardiology, Heart Center, Department of Pediatrics, Head, Toho University School of Medicine, Tokyo, Japan.
- Publication Type:Original Article
- MeSH:
Heart Diseases*;
Heart*;
Humans;
Palivizumab
- From:Journal of the Korean Pediatric Cardiology Society
2007;11(3):149-150
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
